Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Clinical trial NCT03718429 · COMPLETED

Trial details

NCT number: NCT03718429
Sponsor: University of Florida
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Peripheral Arterial Disease Atrial Fibrillation

Start date: 2019-01-14
Primary completion: 2020-02-13
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.